These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24750227)

  • 1. Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by (18) F DOPA-PET/CT scanning.
    Kühnen P; Matthae R; Arya V; Hauptmann K; Rothe K; Wächter S; Singer M; Mohnike W; Eberhard T; Raile K; Lauffer LM; Iakoubov R; Hussain K; Blankenstein O
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):847-54. PubMed ID: 24750227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.
    Meintjes M; Endozo R; Dickson J; Erlandsson K; Hussain K; Townsend C; Menezes L; Bomanji J
    Nucl Med Commun; 2013 Jun; 34(6):601-8. PubMed ID: 23571817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
    Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A
    J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of
    Chroustova D; Trnka J; Pudlac A; Obermannova B; Lambert L
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):279-283. PubMed ID: 32448747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of 23 Chinese children with congenital hyperinsulinism undergoing pancreatectomy.
    Zhang L; Xu ZD; Liu M; Zeng Q; Li RM; Wang JY; Wang HM; Li L; Qin H; Yan J; Wu YJ; Zhu C; Ni GC; Sang YM
    Endokrynol Pol; 2021; 72(5):584-585. PubMed ID: 34292572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation.
    Christiansen CD; Petersen H; Nielsen AL; Detlefsen S; Brusgaard K; Rasmussen L; Melikyan M; Ekström K; Globa E; Rasmussen AH; Hovendal C; Christesen HT
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):250-261. PubMed ID: 29116340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism.
    Yang J; Yuan L; Meeks JK; Zhang N; Li C; Hao R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):619-22. PubMed ID: 23155683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.
    Barthlen W; Blankenstein O; Mau H; Koch M; Höhne C; Mohnike W; Eberhard T; Fuechtner F; Lorenz-Depiereux B; Mohnike K
    J Clin Endocrinol Metab; 2008 Mar; 93(3):869-75. PubMed ID: 18073294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Feasibility of domestic (18)F-DOPA PET/CT scanning in the differential diagnosis of pancreatic lesions in children with hyperinsulinemic hypoglycemia].
    Zhang MY; Ge JJ; Pei Z; Dong KR; Chen L; Wang X; Zhang ZW; Li XJ; Xi L; Cheng RQ; Lu GP; Guan YH; Luo FH
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):785-789. PubMed ID: 29050119
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan.
    Masue M; Nishibori H; Fukuyama S; Yoshizawa A; Okamoto S; Doi R; Uemoto S; Tokumi T; Kasai T; Yorifuji T
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):342-6. PubMed ID: 21521340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis.
    Treglia G; Mirk P; Giordano A; Rufini V
    Pediatr Radiol; 2012 Nov; 42(11):1372-9. PubMed ID: 22885604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid genetic analysis, imaging with 18F-DOPA-PET/CT scan and laparoscopic surgery in congenital hyperinsulinism.
    Cherubini V; Bagalini LS; Ianilli A; Marigliano M; Biagioni M; Carnielli V; Iasonni V; Berbellini A; Hussain K; Gabrielli O
    J Pediatr Endocrinol Metab; 2010; 23(1-2):171-7. PubMed ID: 20432820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.
    Ribeiro MJ; Boddaert N; Bellanné-Chantelot C; Bourgeois S; Valayannopoulos V; Delzescaux T; Jaubert F; Nihoul-Fékété C; Brunelle F; De Lonlay P
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2120-8. PubMed ID: 17661030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.
    Capito C; Khen-Dunlop N; Ribeiro MJ; Brunelle F; Aigrain Y; Crétolle C; Jaubert F; De Lonlay P; Nihoul-Fékété C
    Radiology; 2009 Oct; 253(1):216-22. PubMed ID: 19709999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning.
    Ni J; Ge J; Zhang M; Hussain K; Guan Y; Cheng R; Xi L; Zheng Z; Ren S; Luo F
    Eur J Pediatr; 2019 Aug; 178(8):1161-1169. PubMed ID: 31218401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
    Kauhanen S; Seppänen M; Minn H; Gullichsen R; Salonen A; Alanen K; Parkkola R; Solin O; Bergman J; Sane T; Salmi J; Välimäki M; Nuutila P
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1237-44. PubMed ID: 17227804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of medically-refractory hyperinsulinism.
    Zobel MJ; McFarland C; Ferrera-Cook CT; Padilla BE
    Am J Surg; 2020 Jun; 219(6):947-951. PubMed ID: 31757439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Scheuermann JS; Ernst LM; Freifelder R; Zhuang H; MacMullen C; Becker S; Adzick NS; Divgi C; Alavi A; Stanley CA
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4706-11. PubMed ID: 17895314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lasting 18F-DOPA PET uptake after clinical remission of the focal form of congenital hyperinsulinism.
    Yorifuji T; Hosokawa Y; Fujimaru R; Kawakita R; Doi H; Matsumoto T; Nishibori H; Masue M
    Horm Res Paediatr; 2011; 76(4):286-90. PubMed ID: 21912073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heterogeneity of focal forms of congenital hyperinsulinism.
    Ismail D; Kapoor RR; Smith VV; Ashworth M; Blankenstein O; Pierro A; Flanagan SE; Ellard S; Hussain K
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E94-9. PubMed ID: 22031516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.